Skip to main content
Premium Trial:

Request an Annual Quote

Eric Fung, Ken Welsh, Wenpei Su, Jeffrey Stafford, Iain Mattaj, Fotis Kafatos

Premium

Eric Fung of Ciphergen Biosystems has been promoted to vice president for clinical and medical affairs in the company’s diagnostics division. He joined Ciphergen in 2000 as a lead scientist in its biomarker discovery center laboratories. Fung holds an MD and a PhD in molecular neuroscience from Johns Hopkins University School of Medicine, and a BS in biology from Caltech.


Ken Welsh has been appointed to the scientific advisory board of Health Discovery Corporation, a biotechnology company focused on biomarker and pathway discovery for diagnostic markers and drug targets. Welsh is a professor of clinical genomics at Royal Brompton Hospital and Imperial College in London. He received Bsc, PhD, and DSc degrees from Newcastle University.


CeMines has appointed Wenpei Su as the company’s first director of genomics applications. Su joins CeMines from the Dow Chemical Company, where he led an effort to produce therapeutic proteins. Prior to this, he was employed by Torrey Mesa Research Institute, where as a project leader he applied proteomic and gene-profiling technology to isolate genes involved in complex biological traits. Su holds a PhD in molecular biology and biochemistry from Cornell University.


Syrrx has promoted Jeffrey Stafford to vice president of chemistry. Stafford joined the company in 2002 as senior director of chemistry following an 11-year tenure at GlaxoSmithKline, where he held the position of director of chemistry in oncology.


Iain Mattaj will become director-general of the European Molecular Biology Laboratory, based in Heidelberg, following the departure of Fotis Kafatos, whose term ends next May. Mattaj joined EMBL in 1985, and was appointed scientific director for the organization in 1999. Mattaj will be EMBL’s fourth director-general since the laboratory was founded in 1974.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.